STOCK TITAN

SS Innovations International (SSII) SEC Filings, Mar-May 2026

SSII NASDAQ

SS Innovations International Inc. filings document a Nasdaq-listed surgical robotics issuer and its formal disclosures around the SSi Mantra platform. Recent Current Reports on Form 8-K record product and regulatory updates, telesurgery announcements, conference-related disclosures, financial-results releases and Regulation FD communications.

The filing record also covers capital structure events, including an unregistered private placement of common stock, and identifies the company’s common stock as registered on Nasdaq under SSII. Annual-report and current-report disclosures provide formal context for operating results, product development, clinical and regulatory timelines, forward-looking statements, and the company’s subsidiary-based reporting perimeter.

Rhea-AI Summary

SS Innovations International, Inc. filed a shelf S-3 registration to offer up to $150,000,000 of securities and to register up to 5,016,500 shares of common stock for resale by selling shareholders. The 5,016,500 Shares include 4,474,833 issued in a March 6, 2026 private placement and shares underlying warrants of 41,667 (RCP Warrants, $3.45 exercise) and 500,000 (HCW Warrants, $8.89 exercise). The prospectus states the company will not receive proceeds from selling shareholders’ resale; proceeds to the company will arise only if the warrants are exercised. The company reports a Nasdaq close of $4.02 on April 30, 2026 and that Chairman/CEO Dr. Sudhir Srivastava, through Sushruta Pvt Ltd., beneficially controls approximately 55.85% of the voting power.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.50%
Tags
registration
-
Rhea-AI Summary

SS Innovations International, Inc. filed an 8-K to share a press release about its vision for new surgical robotic technologies unveiled at the Global Multi-Specialty Robotic Surgery Conference (SMRSC 2026) in New Delhi, India, which the Company recently hosted.

The Company highlighted four main innovations under development: the SSi Vimana Aero drone-based surgical system, the SSi Avtara humanoid surgical platform, the SSi Operion mobile operating room, and new single-arm robotic endoscopy and ultrasound assist carts. These concepts emphasize remote, mobile and teleoperated care in challenging environments.

At SMRSC 2026, more than 1,600 in-person and 1,800 virtual participants from 19 nations attended. Expert physicians performed 10 live telesurgeries and 13 live robotic surgeries using the Company’s existing SSi Mantra system across multiple specialties. The filing also reiterates standard forward-looking statement cautions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.83%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.15%
Tags
other
Rhea-AI Summary

SS Innovations International, Inc. Chairman and CEO Sudhir Srivastava reported an indirect transfer of 10,000 shares of common stock as a bona fide gift. The shares were held by Sushruta Pvt. Ltd., an entity in which he has a controlling interest.

Following this non-market gift transaction, entities associated with Srivastava indirectly hold 109,585,767 shares of SS Innovations common stock. The filing reflects a routine personal transfer with no sale proceeds or open-market trading activity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
insider
-
Rhea-AI Summary

SS Innovations International, Inc. is hosting the Global Multi-Specialty Robotic Surgery Conference (SMRSC 2026) in New Delhi, India from April 9–11, 2026. This third installment will gather surgeons, innovators and healthcare leaders to discuss the future of robotic and minimally invasive surgery.

Attendance is expected to exceed last year’s event, which drew more than 1,400 in-person attendees and 600 virtual participants from 17 nations. The conference will feature live telesurgeries, robotic surgeries, technology demonstrations and expert panels. The company highlights its SSi Mantra surgical robotic system, which has been clinically validated in India across more than 100 types of procedures.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.62%
Tags
current report
-
Rhea-AI Summary

SS Innovations International, Inc. insider Barry F. Cohen, COO – Americas and director, tendered 19,000 shares of common stock at a value of $5.58 per share to a non‑affiliated third-party lender. The shares were used to satisfy principal and interest owed on a $100,000 promissory note. Following this non‑market restructuring transaction, Cohen directly holds 7,780,088 shares of SS Innovations common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.62%
Tags
insider
Rhea-AI Summary

SS Innovations International, Inc. director and COO - Americas Barry F. Cohen reported a bona fide gift of 7,000 shares of Common Stock. This non-cash transfer reduced his directly held position to 7,799,088 shares, indicating a routine personal/shareholder gifting event rather than a market sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.80%
Tags
insider
-
Rhea-AI Summary

SS Innovations International, Inc. Chairman and CEO Sudhir Srivastava reported a bona fide gift of 246,000 shares of common stock on behalf of an affiliated entity. The shares were held indirectly through Sushruta Pvt. Ltd., in which he has a controlling interest.

After this gift transfer, the filing shows 109,595,767 shares of common stock still reported as owned indirectly. Because this was a gift with no sale proceeds and represents a small portion of the reported holdings, it reflects a non-market, estate or relationship-driven transfer rather than a trading decision.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.09%
Tags
insider
-
Rhea-AI Summary

SS Innovations International, Inc. filed an amendment to its annual report for the year ended December 31, 2025. The amendment adds Exhibit 97.1, a Clawback Policy, to the exhibits list and includes new Section 302 and 906 officer certifications. The company states the amendment does not change any previously reported financial results or other disclosures in the original annual report.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.63%
Tags
annual report
Rhea-AI Summary

SS Innovations International, Inc. reported new regulatory approvals for its SSi Mantra surgical robotic system in Colombia, Oman, Sri Lanka and Kenya, expanding its addressable markets in Latin America, the Middle East, Africa and South Asia. The system now has regulatory clearance in eleven countries, including India and the United Arab Emirates. As of December 31, 2025, SSi Mantra’s installed base totaled 168 systems across ten countries, with 7,885 cumulative surgeries performed, including 390 cardiac procedures and 121 pediatric surgeries, plus more than 150 telesurgeries. The company also stated it anticipates U.S. FDA review of its 510(k) submission to be completed by mid‑2026 and believes it can obtain European Union CE marking in 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.20%
Tags
current report

FAQ

How many SS Innovations International (SSII) SEC filings are available on StockTitan?

StockTitan tracks 93 SEC filings for SS Innovations International (SSII), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for SS Innovations International (SSII)?

The most recent SEC filing for SS Innovations International (SSII) was filed on November 19, 2026.